A Phase Ib/II Trial of M7824 in Solid Tumors With Microsatellite Instability With Consensus Molecular Subtype 4 Metastatic Colorectal Cancer in Combination With Radiation, or in Colorectal Cancer Patients With Detectable Circulating Tumor DNA Following Definitive Therapy
Phase of Trial: Phase I/II
Latest Information Update: 07 Nov 2019
Price : $35 *
At a glance
- Drugs Bintrafusp alfa (Primary)
- Indications Adenocarcinoma; Colon cancer; Rectal cancer; Solid tumours
- Focus Pharmacodynamics; Pharmacogenomic; Therapeutic Use
- 01 Nov 2019 Planned End Date changed from 1 Nov 2019 to 1 Nov 2020.
- 01 Nov 2019 Planned primary completion date changed from 1 Nov 2019 to 1 Nov 2020.
- 23 May 2019 Planned number of patients changed from 59 to 74.